Casandra
Casandra Test Code QD29954Version 1 (DRAFT)
Performing Lab
CA 125
Also known as: OC125, Cancer Antigen 125, Ovarian Antigen
Clinical Use
Order TestUse
The CA 125 level can provide prognostic information in the follow‑up management of patients with ovarian carcinoma. The assay should be used as an adjunctive test in the management of ovarian cancer patients. CA 125 is not recommended as a cancer screening procedure to detect cancer in the general population.
Special Instructions
Not provided.
Limitations
CA 125 is not intended as a screening test. CA 125 is affected by menstrual cycle, ectopic endometrial tissue.
Test Details
Methodology
Immunoassay
Biomarkers
CA 125
ProteinCA 125 level • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Room temperature: 10 days |
| Refrigerated | Refrigerated: 12 days |
| Frozen | Frozen: 28 days |
Related Tests
Other tests from different labs that may be relevant
Cancer Antigen (CA) 125
Labcorp
Cancer Antigen 125 (CA 125), Serum
Mayo Clinic Lab
Cancer Antigen (CA) 125 (Serial Monitor)
Labcorp
Ovarian Cancer Monitor
Labcorp
Breast Carcinoma-Associated Antigen, Serum
Mayo Clinic Lab
Cancer Antigen 15-3 (CA 15-3), Serum
Mayo Clinic Lab
Cancer Antigen (CA) 27.29
Labcorp
Cancer Antigen (CA) 15-3
Labcorp
Cancer Antigen-Breast (CA 15-3)
ARUP Laboratories
Cancer Antigen 27.29
ARUP Laboratories